首页> 外文期刊>Hepatology international >Pharmacological effects are model specific in animal models of portal hypertension
【24h】

Pharmacological effects are model specific in animal models of portal hypertension

机译:在门静脉高压症动物模型中,药理作用是特定于模型的

获取原文
获取外文期刊封面目录资料

摘要

Portal hypertension is responsible for a major part of complications of liver disease. The increase in portal pressure is attributable to an enhanced vascular resistance followed by an increase in portal venous inflow. The causes of the increase in portal resistance can be prehepatic (i.e., portal venous thrombosis), intrahepatic (most often cirrhosis), or posthepatic (Budd-Chiari syndrome). Furthermore, intrahepatic portal hypertension can be classified as presinusoidal, sinusoidal, and postsinusoidal; the last type being characteristic for human cirrhosis.
机译:门脉高压是肝脏疾病并发症的主要部分。门脉压力的增加归因于血管阻力的增强,随后是门静脉血流的增加。门静脉阻力增加的原因可能是肝前(即门静脉血栓形成),肝内(最常为肝硬化)或肝后(Budd-Chiari综合征)。此外,肝内门脉高压可分为窦前,窦和窦后。最后一种是人类肝硬化的特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号